-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Market Analysis of Chemical Machinery Equipment Network ] In the first half of 2021, the pharmaceutical equipment industry can be said to have both opportunities and challenges, and the industry as a whole has maintained a high degree of prosperity.
Most pharmaceutical machinery companies are expected to have positive results in the first half of the year
.
So in the second half of 2021, what are the trends in the pharmaceutical equipment industry?
Chemical Machinery Equipment Network Market Analysis Chemical Machinery EquipmentMost pharmaceutical machinery companies are expected to have positive results in the first half of the year
.
So in the second half of 2021, what are the trends in the pharmaceutical equipment industry?
Opportunities and challenges coexist in the pharmaceutical machine industry in the first half of the year
Opportunities and challenges coexist in the pharmaceutical machine industry in the first half of the yearWith the end of the first half of 2021, major pharmaceutical machine companies are entering the 2021 semi-annual performance disclosure period one after another, and the performance of companies that have disclosed results are all positive
.
For example, Tofflon released a performance forecast on the evening of July 6.
It is expected that the net profit attributable to shareholders of listed companies in the first half of 2021 will be about 310 million to 344 million yuan; The net profit was 58 million yuan to 68 million yuan, an increase of 71.
82%-101.
44% over the same period of the previous year
.
.
For example, Tofflon released a performance forecast on the evening of July 6.
It is expected that the net profit attributable to shareholders of listed companies in the first half of 2021 will be about 310 million to 344 million yuan; The net profit was 58 million yuan to 68 million yuan, an increase of 71.
82%-101.
44% over the same period of the previous year
.
From the perspective of the environment in which the pharmaceutical machine industry is located in the first half of the year, it can be said that opportunities and challenges coexist
.
On the one hand, there are many positive factors.
For example, the production demand for equipment is continuously expanding.
Since the current delivery time of imported equipment cannot meet the needs of pharmaceutical companies, the domestic pharmaceutical machinery equipment industry has ushered in huge development opportunities
.
At the same time, with the accelerated development of the pharmaceutical manufacturing industry, a new round of investment in fixed assets is emerging, which will inject growth momentum into the pharmaceutical equipment industry
.
According to a research report released by Southwest Securities, pharmaceutical companies have begun a new round of fixed asset investment, and the growth of the pharmaceutical machinery industry has accelerated, with a year-on-year growth rate of more than 15%
.
.
On the one hand, there are many positive factors.
For example, the production demand for equipment is continuously expanding.
Since the current delivery time of imported equipment cannot meet the needs of pharmaceutical companies, the domestic pharmaceutical machinery equipment industry has ushered in huge development opportunities
.
At the same time, with the accelerated development of the pharmaceutical manufacturing industry, a new round of investment in fixed assets is emerging, which will inject growth momentum into the pharmaceutical equipment industry
.
According to a research report released by Southwest Securities, pharmaceutical companies have begun a new round of fixed asset investment, and the growth of the pharmaceutical machinery industry has accelerated, with a year-on-year growth rate of more than 15%
.
On the other hand, pharmaceutical machine companies are also facing the challenges of capacity expansion and rising costs
.
In terms of production capacity, in the case of strong demand for equipment, how to increase production capacity to meet the growth of market demand is a problem that pharmaceutical machine companies need to deal with
.
In order to cope with the expansion of production capacity, large pharmaceutical machine companies such as Chutian and Tofflon have taken measures such as building new factories and new projects this year to prepare for the expansion of production capacity
.
In terms of cost, for example, the price index of steel materials and labor costs have risen, which brings challenges in cost control to drug delivery machine companies
.
In recent years, with the continuous deepening of the national strategy for new infrastructure construction, emerging technologies such as 5G, big data, and artificial intelligence have gradually extended their tentacles to the field of pharmaceutical equipment, which is expected to empower the high-quality development of the pharmaceutical machinery industry, help pharmaceutical companies achieve stable production and overproduction, and Reduce costs and labor dependence
.
Some large pharmaceutical machine companies are also seizing the opportunity to accelerate the deployment of intelligent manufacturing
.
.
In terms of production capacity, in the case of strong demand for equipment, how to increase production capacity to meet the growth of market demand is a problem that pharmaceutical machine companies need to deal with
.
In order to cope with the expansion of production capacity, large pharmaceutical machine companies such as Chutian and Tofflon have taken measures such as building new factories and new projects this year to prepare for the expansion of production capacity
.
In terms of cost, for example, the price index of steel materials and labor costs have risen, which brings challenges in cost control to drug delivery machine companies
.
In recent years, with the continuous deepening of the national strategy for new infrastructure construction, emerging technologies such as 5G, big data, and artificial intelligence have gradually extended their tentacles to the field of pharmaceutical equipment, which is expected to empower the high-quality development of the pharmaceutical machinery industry, help pharmaceutical companies achieve stable production and overproduction, and Reduce costs and labor dependence
.
Some large pharmaceutical machine companies are also seizing the opportunity to accelerate the deployment of intelligent manufacturing
.
What are the industry development trends in the second half of 2021?
What are the industry development trends in the second half of 2021? First, with the advancement of the medical reform policy, the innovation and development of the pharmaceutical industry has accelerated.
At the same time, with the continuous rise of emerging biotechnology companies and the expansion of the CDMO industry, it will bring new opportunities for the pharmaceutical equipment industry.
The market size of the entire pharmaceutical machine industry will continue to expand
.
At the same time, with the continuous rise of emerging biotechnology companies and the expansion of the CDMO industry, it will bring new opportunities for the pharmaceutical equipment industry.
The market size of the entire pharmaceutical machine industry will continue to expand
.
Second, in recent years, under the guidance of policies and policies such as "lucid waters and lush mountains are invaluable assets", as well as the continuous improvement of environmental protection standards and stricter supervision, environmental protection issues have attracted the attention of the pharmaceutical industry.
In the process of accelerating innovation in the pharmaceutical industry , the demand for high-end environmentally friendly pharmaceutical machines is expected to grow and usher in development opportunities
.
In this context, pharmaceutical machine companies need to carry out a technological revolution in production equipment to help the high-quality and sustainable development of the pharmaceutical industry
.
In the process of accelerating innovation in the pharmaceutical industry , the demand for high-end environmentally friendly pharmaceutical machines is expected to grow and usher in development opportunities
.
In this context, pharmaceutical machine companies need to carry out a technological revolution in production equipment to help the high-quality and sustainable development of the pharmaceutical industry
.
Third, the domestic pharmaceutical machine industry has long had problems such as many small and medium-sized enterprises, low industry concentration, and fierce competition between low-end and mid-end products.
These bottlenecks also hinder the high-quality development of the industry
.
As imported equipment is limited by the delay in delivery, the pace of domestic substitution of imports is accelerated, and the industry structure is expected to be optimized.
Domestic pharmaceutical machine giants will gain a competitive advantage in the wave of domestic substitution and increase market share
.
The industry predicts that the domestic pharmaceutical machine industry will gradually become standardized and high-end in the future, and the industry concentration will continue to increase
.
These bottlenecks also hinder the high-quality development of the industry
.
As imported equipment is limited by the delay in delivery, the pace of domestic substitution of imports is accelerated, and the industry structure is expected to be optimized.
Domestic pharmaceutical machine giants will gain a competitive advantage in the wave of domestic substitution and increase market share
.
The industry predicts that the domestic pharmaceutical machine industry will gradually become standardized and high-end in the future, and the industry concentration will continue to increase
.
Fourth, with the upgrading of the pharmaceutical industry structure and the adjustment of the needs of pharmaceutical companies, in order to reduce costs and improve efficiency, pharmaceutical companies will prefer suppliers who can provide solutions, rather than pharmaceutical machines with single products and weak R&D capabilities.
Enterprises, and even some customers, require customized products based on special needs, which will also put forward certain requirements on the product development and design capabilities, production capabilities and service levels of pharmaceutical machine companies
.
Enterprises, and even some customers, require customized products based on special needs, which will also put forward certain requirements on the product development and design capabilities, production capabilities and service levels of pharmaceutical machine companies
.
Original title: What are the trends in the pharmaceutical equipment industry in the second half of 2021?
